Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bruker Corp (BRKR)
NASDAQ:BRKR
Holding BRKR?
Track your performance easily
BRKR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$48.07 - $94.86
Previous CloseN/A
Volume340.61K
Average Volume (3M)1.40M
Market Cap
$8.95B
Enterprise Value$12.80B
Total Cash (Recent Filing)$500.30M
Total Debt (Recent Filing)$391.60M
Price to Earnings (P/E)28.4
Beta1.13
Next Earnings
Feb 18, 2025EPS Estimate
0.74Last Dividend Ex-Date
Dec 02, 2024Dividend Yield0.34%
Share Statistics
EPS (TTM)2.08
Shares Outstanding151,598,240
10 Day Avg. Volume1,591,419
30 Day Avg. Volume1,395,240
Standard Deviation0.10
R-Squared0.39
Alpha-0.00584
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.76
Price to Cash Flow (P/CF)58.20
P/FCF Ratio385.60
Enterprise Value/Market Cap1.43
Enterprise Value/Revenue3.95
Enterprise Value/Gross Profit8.46
Enterprise Value/Ebitda21.90
Forecast
1Y Price Target
$74.20Price Target Upside30.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Bruker News
PremiumCompany Announcements
Bruker Shares Limited Information Under SEC Regulations
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBRKR's fourth quarter total revenue is expected to exceed analyst expectations, showcasing strong financial performance amid a challenging market environment.
Growth OpportunitiesSecular trends in semiconductor metrology, renewable energy, and lab automation offer BRKR high-margin growth opportunities, positioning the company for long-term success.
Product StrategyBRKR's products are unaffected by recent regulatory rulings due to their unique bottom-up proteomics approach, shielding them from potential legal challenges.
Bears Say
Financial PerformanceBRKR missed 3Q24 expectations and cut numbers as pharma headwinds finally caught up to the company after approximately two years of outperforming peer and market growth.
Market DemandOrganic growth came down to 3.1% in the quarter, largely due to a pause in China instrument ordering and a delayed biopharma recovery.
Revenue GuidanceRevenue guidance for the fiscal year was lowered by approximately $60 million due to factors like a delayed recovery in China and weaker biopharma results.
---
Ownership Overview
26.37% Insiders
30.04% Mutual Funds
6.37% Other Institutional Investors
20.78% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BRKR FAQ
What was Bruker Corp’s price range in the past 12 months?
Bruker Corp lowest stock price was $48.07 and its highest was $94.86 in the past 12 months.
What is Bruker Corp’s market cap?
Bruker Corp’s market cap is $8.95B.
When is Bruker Corp’s upcoming earnings report date?
Bruker Corp’s upcoming earnings report date is Feb 18, 2025 which is in 27 days.
How were Bruker Corp’s earnings last quarter?
Bruker Corp released its earnings results on Nov 05, 2024. The company reported $0.6 earnings per share for the quarter, missing the consensus estimate of $0.601 by -$0.001.
Is Bruker Corp overvalued?
According to Wall Street analysts Bruker Corp’s price is currently Undervalued.
Does Bruker Corp pay dividends?
Bruker Corp pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 0.34%. See more information on Bruker Corp dividends here
What is Bruker Corp’s EPS estimate?
Bruker Corp’s EPS estimate is 0.74.
How many shares outstanding does Bruker Corp have?
Bruker Corp has 151,598,240 shares outstanding.
What happened to Bruker Corp’s price movement after its last earnings report?
Bruker Corp reported an EPS of $0.6 in its last earnings report, missing expectations of $0.601. Following the earnings report the stock price went up 3.356%.
Which hedge fund is a major shareholder of Bruker Corp?
Currently, no hedge funds are holding shares in BRKR
---
Bruker Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$74.20 (30.45% Upside)
$74.20 (30.45% Upside)
Blogger Sentiment
Bullish
BRKR Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 8.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $4.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.5%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.15%
12-Months-Change
Fundamentals
Return on Equity
20.22%
Trailing 12-Months
Asset Growth
60.04%
Trailing 12-Months
Company Description
Bruker Corp
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.
---
BRKR Company Deck
---
BRKR Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While Bruker showed strong revenue growth driven by strategic acquisitions and segments like semiconductor metrology, the company faced significant challenges in the biopharma and China markets, leading to reduced fiscal year guidance and impacting margins and earnings. These factors resulted in a more cautious outlook for the near term.Read More>---
BRKR Stock 12 Month Forecast
Average Price Target
$74.20
▲(30.45% Upside)
Technical Analysis
Best Analysts Covering BRKR
1 Year
1 Year Success Rate
17/26 ratings generated profit
1 Year Average Return
+11.23%
reiterated a buy rating 6 days ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 65.38% of your transactions generating a profit, with an average return of +11.23% per trade.
---